Biodiscovery from rare actinomycetes: an eco-taxonomical perspective

Area of Science:

• Microbiology
• Natural Products Chemistry
• Drug Discovery

Background:

• Microbial natural products, particularly from Actinomycetales, are vital sources of novel bioactive compounds.
• The increasing prevalence of drug-resistant bacteria necessitates the discovery of new therapeutic agents.
• Actinomycetes remain a significant focus for identifying compounds with therapeutic potential.

Purpose of the Study:

• To highlight the importance of discovering lesser-known and novel actinomycetes for drug development.
• To emphasize the synergistic role of conventional ecological, taxonomic, physiological, and metabolic studies with modern molecular techniques.
• To outline a strategy for identifying novel actinomycetes and their potential as sources of new drug candidates.

Main Methods:

• Leveraging advancements in genomics and metagenomics for targeted detection and isolation of bioactive actinomycetes.
• Integrating knowledge from historical studies on actinomycete ecology, taxonomy, physiology, and metabolism.
• Combining traditional research approaches with cutting-edge molecular tools.

Main Results:

• Genomics and metagenomics enhance the targeted search for bioactive actinomycetes.
• A comprehensive understanding of actinomycetes, integrating historical and molecular data, is key to new discoveries.
• This integrated approach is expected to reveal previously undetected bioactive actinomycetes, including novel Streptomyces species.

Conclusions:

• Continued exploration of Actinomycetales is essential for novel bioactive compound discovery.
• The integration of traditional and molecular approaches is crucial for identifying new drug leads.
• This strategy will facilitate the discovery of novel actinomycetes, including Streptomyces, as sources for new therapeutic agents against resistant infections.